Faisal Miqad K. Albaqami

Dr. Faisal Miqad K. Albaqami

biology Department, Islamic University of Madinah, Medina, Al Madīnah al Munawwarah, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2025 in Natural Products and Bioprospecting
Verified
Journal Article
Open access
PDF file
Hesham El-SeediHesham El-Seedi
Hesham El-Seedi
Mohamed S. RefaeyMohamed S. Refaey
Mohamed S. Refaey
Nizar EliasNizar Elias
Nizar Elias
MFMohamed Fahmi
Mohamed Fahmi
FAFaisal Miqad K. Albaqami
Faisal Miqad K. Albaqami
SKShaden Khalifa
Shaden Khalifa
Marine natural products have long been recognized as a vast and diverse source of bioactive compounds with potential therapeutic applications, particularly in oncology. This review provides an updated overview of the significant advances made in the discovery and development of marine-derived anticancer drugs between 2019 and 2023. With a focus on recent research findings, the review explores the rich biodiversity of marine organisms, including sponges, corals, algae, and microorganisms, which have yielded numerous compounds exhibiting promising anticancer properties. Emphasizing the multifaceted mechanisms of action, the review discusses the molecular targets and pathways targeted by these compounds, such as cell cycle regulation, apoptosis induction, angiogenesis inhibition, and modulation of signaling pathways. Additionally, the review highlights the innovative strategies employed in the isolation, structural elucidation, and chemical modification of marine natural products to enhance their potency, selectivity, and pharmacological properties. Furthermore, it addresses the challenges and opportunities associated with the development of marine-derived anticancer drugs, including issues related to supply, sustainability, synthesis, and clinical translation. Finally, the review underscores the immense potential of marine natural products as a valuable reservoir of novel anticancer agents and advocates for continued exploration and exploitation of the marine environment to address the unmet medical needs in cancer therapy Graphical Abstract

9 December 2024 in Life
Verified
Journal Article
Open access
PDF file
MKmanal kowdiary
manal kowdiary
ZAZinab ALAtawi
Zinab ALAtawi
AAAmirah Mohammad Alhowiti
Amirah Mohammad Alhowiti
MAMohamed Abdel-Aal Amin
Mohamed Abdel-Aal Amin
HDHussam Daghistani
Hussam Daghistani
Amr FoudaAmr Fouda
Amr Fouda
This study examined the phytochemical profile and biomedical activities of Nitraria retusa, a halophytic and drought-resistant shrub. HPLC analysis showed gallic acid (1905.1 μg/g), catechin (1984.1 μg/g), and ellagic acid (2671.1 μg/g) as the primary constituents, while FT-IR analysis revealed a complex organic profile with significant functional groups. The extract demonstrated strong antioxidant activity in DPPH assays, outperforming ascorbic acid (IC50 = 18.7 ± 1.0 μg/mL) with an IC50 of 16.4 ± 4.4 μg/mL. It demonstrated specific antiproliferative effects on cancer cell lines as it showed selective cytotoxicity against cancer cell lines; normal WI38 cells were largely unaffected, showing 50.0% viability at 125 μg/mL. The most sensitive cell line was Caco2, which showed 50.0% viability at 125 μg/mL. Anti-diabetic properties were exhibited by means of inhibition of α-amylase (IC50 = 68.2 ± 4.2 μg/mL) and α-glucosidase (IC50 = 22.8 ± 3.3 μg/mL). Additionally, antimicrobial activity was observed to be broad-spectrum, and it was most effective against E. coli (32.6 mm inhibition zone at 400 μg/mL) and Penicillium glabrum (35.3 mm at 400 μg/mL). These findings highlight the potential of N. retusa in developing plant-based therapeutic approaches.

1 September 2024 in Journal of Biosafety and Biosecurity
Verified
Journal Article
Open access
Ranjan K. MohapatraRanjan K. Mohapatra
Ranjan K. Mohapatra
AMAhmed Mahal
Ahmed Mahal
PMPranab K. Mohapatra
Pranab K. Mohapatra
ASAshish K. Sarangi
Ashish K. Sarangi
SMSnehasish Mishra
Snehasish Mishra
ARAli A. Rabaan
Ali A. Rabaan

2 February 2026 in RSC Advances
Verified
Journal Article
Open access
AAAnes A. Al-Sharqi
Anes A. Al-Sharqi
MEMohammed E. Eissa
Mohammed E. Eissa
DADareen Alyousfi
Dareen Alyousfi
AAAhmed Eid Alharbi
Ahmed Eid Alharbi
IIIBRAHIM IBRAHIM
IBRAHIM IBRAHIM
Ahmed GhareebAhmed Ghareeb
Ahmed Ghareeb
Selenium–copper bimetallic nanoparticles (Se–Cu BMNPs) were synthesized using metabolic extracts from the marine bacterium Bacillus licheniformis LHG166 isolated from the Red Sea.

20 October 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
MGMAZEN GHAITH
MAZEN GHAITH
RARiyad Almaimani
Riyad Almaimani
Ahmed GhareebAhmed Ghareeb
Ahmed Ghareeb
MHMahmoud M. Habibullah
Mahmoud M. Habibullah
SASozan M. Abdelkhalig
Sozan M. Abdelkhalig
HEHanaa F Abd el-kareem
Hanaa F Abd el-kareem
Marine bacteria are a valuable source of bioactive polysaccharides with therapeutic potential. In our previous study, we identified an exopolysaccharide produced by Kocuria sp. strain AG5 (EPSR5) isolated from the Red Sea, and demonstrated that it is a high-molecular weight, acidic heteropolysaccharide rich in sulfate (25.6%) and uronic acid (21.77%) groups. In the current study, we expanded the structural characterization and biological evaluation of EPSR5. GC–MS and HPLC analyses revealed glucose as the major monosaccharide, accompanied by xylose, arabinose, and glucuronic acid, confirming its heteropolysaccharide and polyanionic character. Thermal analysis (TGA) demonstrated stability up to 257 °C, while SEM–EDX revealed a porous, flake-like morphology enriched in oxygen, sodium, and phosphorus, suggesting phosphorylation and ionic associations. The biological activity of EPSR5 was assessed through a range of pharmacological assays. Antimicrobial testing against seven pathogenic microbes, including two fungal strains (Candida albicans, Mucor circinelloides), two Gram-positive bacteria (Enterococcus faecalis, Staphylococcus aureus), and three Gram-negative bacteria (Escherichia coli, Salmonella typhi, Helicobacter pylori), demonstrated potent inhibitory effects. EPSR5 showed notable inhibition zones up to 30 mm against E. faecalis and 27 mm against H. pylori, with MIC/MBC values as low as 7.8/15.62 μg mL−1 and 15.62/15.62 μg mL−1, respectively. Significant antibiofilm activity was also observed, with inhibition rates reaching up to 96.54% against E. faecalis and 97.39% against H. pylori, in a concentration-dependent manner. Antioxidant potential was confirmed via TAC and FRAP assays, showing values of 62.8 ± 0.3 and 114.9 ± 0.5 μg ascorbic acid equivalents per mg, respectively. EPSR5 exhibited antidiabetic activity by inhibiting α-glucosidase and α-amylase enzymes with IC50 values of 17.06 μg mL−1 and 66.35 μg mL−1, respectively, comparable to Acarbose. Additionally, EPSR5 inhibited pancreatic lipase with an IC50 of 41.39 μg mL−1 and suppressed 90.1% of enzyme activity at 1000 μg mL−1. In wound healing assays, EPSR5 promoted fibroblast migration and accelerated wound closure, reducing the wound area within 48 hours, achieving 71.85% closure compared to 66.24% in control cells. Overall, these findings suggest that EPSR5 from Kocuria sp. AG5 exhibits multifaceted bioactivities with promising therapeutic potential for antimicrobial, antioxidant, antidiabetic, and wound healing applications.

21 June 2024 in Agronomy
Verified
Journal Article
Open access
PDF file
IHIjaz Hussain
Ijaz Hussain
MJMuhammad Ramzan Saeed Ashraf Janjua
Muhammad Ramzan Saeed Ashraf Janjua
AHAtta ul Haq
Atta ul Haq
SHSadaf ul Hassan
Sadaf ul Hassan
FAFaisal Miqad K. Albaqami
Faisal Miqad K. Albaqami
SNSyed Ali Raza Naqvi
Syed Ali Raza Naqvi
The Asian region of earth has a rich agriculture system that provides extensive opportunities to boost pharmaceutical and nutritional research to address the use of food crops for health benefits and potential clinical applications. The traditionally cropped green leaf vegetable indigenously known as Bathu and botanically known as Chenopodium album (C. album) is traditionally used as a sedative, blood purifier, hepatoprotectant, diuretic, and antiscorbutic laxative. In this study, we investigated the anti-infection potential, anti-diabetic potential, and mineral composition of indigenously cultivated C. album plant extracts. Methanol and n-hexane solvents were used to extract phytochemicals at different extraction conditions. The maximum yield of 12.72 ± 0.36 g/100 g extract was obtained in methanol with 200 rpm shaking, 200 mL solvent, and an 8 h extraction period. Under the same conditions, n-hexane gave 2.09 ± 0.29 g/100 g extract. Good alpha-amylase inhibition efficiency was shown by the n-hexane extracts, while the methanol extracts showed good urease inhibition potential. The H6 extract had the lowest IC50 (8.16 ± 0.2 ug/mL) as compared to the standard acarbose (9.27 ± 0.6 ug/mL). Similarly, the M6 extract revealed a significant urease inhibitory potential, i.e., IC50 of 18.77 ± 0.6 ug/mL, which was close to the standard thiourea (IC50: 19.09 ± 0.7 ug/mL). Regarding the antibacterial study, the M6 extract showed 16.55 ± 0.57 mm ZOI against E. coli and 15.54 ± 0.55 mm in the case of S. aureus, as compared to the standard ciprofloxacin, which showed 26.08 ± 0.73 mm, and penicillin, which showed 21.12 ± 0.81 mm ZOI. Mineral profiling was investigated by ICP-OES, which showed significant amounts of Mg and Fe in all extracts. Our findings tend to show that systematic harvesting and utilization of this vegetable crop could be recommended as an alternative nutritional therapy in the management of internal infections and diabetes.